Biogen (BIIB) Research & Development (2016 - 2025)
Historic Research & Development for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $509.4 million.
- Biogen's Research & Development fell 75.98% to $509.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.8 billion, marking a year-over-year decrease of 1018.53%. This contributed to the annual value of $1.8 billion for FY2025, which is 1018.53% down from last year.
- According to the latest figures from Q4 2025, Biogen's Research & Development is $509.4 million, which was down 75.98% from $436.1 million recorded in Q3 2025.
- Biogen's 5-year Research & Development high stood at $736.3 million for Q3 2023, and its period low was $399.0 million during Q2 2025.
- For the 5-year period, Biogen's Research & Development averaged around $546.8 million, with its median value being $538.9 million (2022).
- Within the past 5 years, the most significant YoY rise in Biogen's Research & Development was 160072.64% (2021), while the steepest drop was 5947.51% (2021).
- Quarter analysis of 5 years shows Biogen's Research & Development stood at $699.5 million in 2021, then dropped by 14.0% to $601.6 million in 2022, then dropped by 7.86% to $554.3 million in 2023, then dropped by 7.4% to $513.3 million in 2024, then decreased by 0.76% to $509.4 million in 2025.
- Its Research & Development was $509.4 million in Q4 2025, compared to $436.1 million in Q3 2025 and $399.0 million in Q2 2025.